Skip to main content
. 2023 Jul 10;80(8):860–867. doi: 10.1001/jamaneurol.2023.2125

Figure 1. Initiation Episodes of Disease-Modifying Therapies (DMTs) in Adults (18 to 64 Years Old) With Multiple Sclerosis, 2001 Through 2020.

Figure 1.

This figure displays the proportion of total new use episodes per year attributable to each individual DMT for adult patients. A DMT claim was considered a new use episode if a patient had no claim for the same DMT within 1 year prior to the current DMT claim. Only DMTs that were frequently used in our data are shown in this figure, so proportions presented here may not sum to 100%. Data for all DMTs are shown in eTable 2 in Supplement 1.